CHEMBL402

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:contraindication asthma
heart block
severe bradycardia
cardiogenic shock
gptkbp:drugClass beta blocker
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion gptkb:kidney
gptkbp:hasChEMBLId gptkb:CHEMBL402
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasSMILES CC(C)NCC(CO)OC1=CC=C(C=C1)CC(=O)N
gptkbp:hasUNII 50VV3VW0TI
gptkbp:hasWikipediaPage https://en.wikipedia.org/wiki/Atenolol
https://www.w3.org/2000/01/rdf-schema#label CHEMBL402
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
gptkbp:isApprovedDrug true
gptkbp:legalStatus prescription only
gptkbp:manufacturer gptkb:AstraZeneca
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:MeSH_ID D000889
gptkbp:metabolism minimal hepatic
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID gptkb:D00222
2162
CHEBI:2269
DB00335
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
fatigue
bradycardia
cold extremities
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
gptkbp:target gptkb:ADRB1
gptkb:ADRB2
gptkbp:bfsParent gptkb:ketamine
gptkb:MDMA
gptkbp:bfsLayer 6